treatment to move beyond “preventative” remedies, in favor of “pre-emptive, final-solution” approach
The medical journal Cell has published a research paper on using an extremely dangerous psychotropic pharmaceutical to treat cancer; one that has traditionally been used to treat schizophrenia.
Scientists are claiming that according to their extensive research, which consisted of analyzing thousands of different drugs to determine if they possessed anti-cancer effects, it is Thiroridazine — a “last resort” drug for schizophrenics — that is now purported to kill cancer stem cells.
Thioridazine is expected to be used to select and eradicate cancer stem cells that are found in leukemia and several other cancers such as breast, blood, brain, prostate, ovarian, lung and gastrointestinal.
Scientists claim that this hazardous pharmaceutical can be administered in cancer therapies, without the health-threatening side effects of current drugs on the market. It is being advertised as an alternative to chemotherapy and radiation.
A robotic stem cell screening system was devised by the research team to siphon through large amounts of drugs and previously unpublished data and drugs that are available on the market today. Thousands of chemical compounds were screened for potential effects on specifically breast cancer and leukemia.
“We discovered the drug by creating a new way of looking at different chemicals,” said Mick Bhatia, the principal investigator for the study and scientific director of McMaster’s Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine.
In order to do that, we have to put cancer stem cells in a dish, but also have normal stem cells to also test the compounds. We were able to do this with a robotic system, fully automated, that allowed us to go through 10 or 15 compounds [at first]. Now we can do this with thousands of compounds, eventually arriving at this drug that doesn’t do anything to normal stem cells, but kills cancer stem cells.
The unusual aspect of our finding is the way this human-ready drug actually kills cancer stem cells; by changing them into cells that are non-cancerous.
The praise Thioridazine is receiving omits the dangerous effects that this drug causes in humans.
- Urinary tract infections
- Slowed movements
- Inability to produce facial expressions
- Parkinson’s disease
- Irregular heart beat
- Sudden death
Thioridazine is classified as a conventional antipsychotic. Its prime function is to reduce the brain’s ability to process excitement; effectively rendering the patient docile and even-tempered.
There is a strong possibility of committing suicide while on this drug.
Bhatia’s study asserts that this discovery could inspire a new frontier in cancer therapies. He stated that there are an estimated 12 existing drugs that pose a “good potential for the same response.”
The researchers are not stopping with Thioridazine; they are moving onto other possible uses for already approved drugs.
Bhatia’s team is anxious to begin human trials with plans to use this pharmaceutical on leukemia patients. By studying patients whose cancer is in remission, the researchers hope to find that thioridazine will prevent a multitude of cancers.
Unethical human experimentation in the United States
There have been numerous experiments performed on human test subjects in the United States that have been considered unethical, and were often performed illegally, without the knowledge, consent, or informed consent of the test subjects.
The experiments include: the deliberate infection of people with deadly or debilitating diseases, exposure of people to biological and chemical weapons, human radiation experiments, injection of people with toxic and radioactive chemicals, surgical experiments, interrogation/tortureexperiments, tests involving mind-altering substances, and a wide variety of others. Many of these tests were performed on children, the sick, and mentally disabled individuals, often under the guise of “medical treatment”. In many of the studies, a large portion of the subjects werepoor racial minorities or prisoners.
Funding for many of the experiments was provided by United States government, especially the Central Intelligence Agency, United States military and federal or military corporations. The human research programs were usually highly secretive, and in many cases information about them was not released until many years after the studies had been performed.